Abstract. Administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mammals causes damage to the nigrostriatal dopaminergic pathway similar to that observed in Parkinson disease (PD). Reactive oxygen species (ROS) are thought to be involved in the pathogenesis of MPTP-mediated dopaminergic neurodegeneration. To further clarify the role of superoxide anion radical (•O 2 Ϫ ) and to study the possible involvement of hydroperoxides in MPTP-mediated neurodegeneration, MPTP neurotoxicity was induced in mice deficient in either CuZn superoxide dismutase (SOD), a scavenger enzyme for •O 2 Ϫ , or cellular glutathione peroxidase (GSHPx-1), a scavenger enzyme for hydroperoxides. Littermate control and homozygous deficient mice were injected intraperitoneally with a total cumulative dose of 0, 75, or 150 mg/kg of MPTP delivered over 5 d. All mice were killed 5 d after the last injection and the brains were processed for immunohistological analysis for tyrosine hydroxylase (TH) in the striatum and the substantia nigra pars compacta (SNc), as well as for direct measurements of dopamine concentrations in the striatum. The intensity of TH immunoreactivity in the striatum was evaluated by measuring the relative optical density (OD) with NIH IMAGE, and expressed as Log (OD of striatum)/Log (OD of white matter). Degeneration of TH-containing neurons was assessed by counting TH-positive neurons in the SNc. We found that this MPTP exposure protocol produced dose-dependent depletion of TH immunoreactivity and dopamine in the striatum in littermate control mice and both strains of knockout mice; however, reduction in TH immunoreactivity and dopamine content were significantly greater in CuZn-SOD or GSHPx-1 deficient mice compared with littermate controls. MPTP exposure did not significantly alter the number of TH-positive neurons in the SNc in littermate control or knockout mice. These data suggest that some of the deleterious effects of MPTP on striatal dopaminergic nerve terminals are mediated by both •O 2 Ϫ and hydroperoxides, and that they occur prior to dopaminergic neurodegeneration in the SNc. The similarity between the MPTP model and PD raises the possibility that both types of ROS may play a significant role in the early pathogenesis of dopaminergic neurodegeneration in PD.
INTRODUCTION
Parkinson disease (PD) is characterized clinically by bradykinesia, resting tremor, and rigidity, and is due to progressive degeneration of dopaminergic neurons in the zona compacta of the substantia nigra pars compacta (SNc) (1) . The causes of dopaminergic neurodegeneration in PD remain unclear. Because of the limitations associated with investigations of postmortem brain samples from PD patients, many investigators have focused their efforts on experimental models of PD such as the one produced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). MPTP exposure causes an irreversible and severe parkinsonism that is clinically and pathologically similar to idiopathic PD, i.e. marked reduction in the dopaminergic neurons within the SNc, decrease in striatal tyrosine hydroxylase (TH) activity, and decreased dopamine (DA) levels in the striatum (2, 3) . Although the precise mechanisms by which MPTP destroys dopaminergic neurons remain controversial, the toxic effects of MPTP appear to depend on its biotransformation to Nmethyl-4-phenylpyridinium (MPP ϩ ) by monoamine oxidase (MAO) (4, 5) . MPP ϩ , a potent mitochondrial toxin, is thought to be the active neurotoxin since MAO inhibitors significantly decrease MPTP-induced toxicity in the brain (5) and mice deficient in MAO are resistant to MPTP-mediated neurotoxicity (6) .
Damage to mitochondria by MPP ϩ is thought to involve impairment of energy metabolism leading to increased free radical generation. Increased generation of superoxide anion radical (•O 2 Ϫ ) and hydroxyl radical (•OH) are associated with MPP ϩ in vitro and with MPTP in vivo (7) (8) (9) . Furthermore, genetically altered mice with increased CuZn superoxide dismutase (CuZn-SOD) or Mn-SOD are resistant to MPTP-induced neurotoxicity (10, 11) . Both CuZn-SOD and Mn-SOD detoxify •O 2 Ϫ . Animals treated with antioxidants such as vitamin E and desferrioxamine are resistant to MPTP-induced neurotoxicity (12) . Finally, pretreatment of animals with diethyl dithiocarbamate (DDTC), an inhibitor of SOD, enhances MPTP toxicity (13) , although DDTC has other effects beyond inhibition of SOD.
While the above findings secure a role for reactive oxygen species (ROS) in the pathogenesis of MPTP-induced neurotoxicity, they do not differentiate the relative significance of different ROS. For example, MPTP toxicity may be mediated by •O 2 Ϫ reacting with nitric oxide (NO•) to form peroxynitrite, leading to protein nitration (14) . Experiments showing that inhibition of NO• synthase (NOS) protects mice against MPTP-induced neurotoxicity support this idea (14) . Alternatively, •O 2 Ϫ may dismutate to hydrogen peroxide (H 2 O 2 ), which produces •OH in the presence of transitional metals such as iron through Fenton chemistry.
•OH is a highly reactive molecule that can inhibit protein function, damage nucleic acids, and initiate lipid peroxidation (15) . It has been shown that MPTP mediates •OH production in animals (9) and that PD is clearly associated with an increased level of nigral iron (16) . Finally, although ROS production is associated with MPTP exposure, it is possible that ROS generation is a consequence of widespread neural death and tissue response to injury (17) , and not causally related to MPTP-induced neurodegeneration.
To evaluate further the role of •O 2 Ϫ and the possible involvement of hydroperoxides such as H 2 O 2 in the pathogenesis of MPTP toxicity, we performed experiments using homozygous Sod1 deficient (Sod1 -/-) mice (Sod1 encodes CuZn-SOD) and homozygous Gpx1 deficient (Gpx1 -/-) mice (Gpx1 encodes cellular glutathione peroxidase). CuZn-SOD and glutathione peroxidase (GSHPx-1) are scavenger enzymes for •O 2 Ϫ and hydroperoxides, respectively. Both littermate control and knockout mice were injected intraperitoneally with increasing doses of MPTP, and their brains examined for loss of TH-containing nerve terminals in the striatum, striatal dopamine levels, and TH-containing neurons in the SNc. Mice of different strains or ages show marked differences in developing neurological and neuropathological effects after exposure to MPTP (2, 3) . However, the development of significant loss of dopaminergic neurons in the SNc after MPTP administration usually does not occur for at least 2 wk. To minimize potential ROS generation from widespread cell death (17), we chose a less severe MPTP model and harvested brain tissue at an earlier time in this study.
MATERIALS AND METHODS

Animals
Generation of Sod1
-/-and Gpx1 -/-mice has previously been described in detail (18, 19) . In brief, wild-type (C57BL/6) and homozygous knockout mice were produced by breeding heterozygous knockout mice and identified by Southern blot analysis of tail DNA. Pervious experiments have demonstrated the absence of CuZn-SOD or GSHPx-1 activity in brain homogenates from Sod1 -/-or Gpx1 -/-mice, respectively (18, 19) .
MPTP Administration
Wild-type and homozygous deficient mice (25-30 g ) at 10 wk of age were injected intraperitoneally with MPTP (Aldrich) at 0, 15, 30, or 60 mg/kg·d for 5 d for a total cumulative dose of 0, 75, 150, or 300 mg/kg of MPTP, and killed following pentobarbital anesthesia on day 5 after the last injection. Mouse brain was perfusion fixed through the heart with 4% paraformaldehyde in phosphate buffered saline (PBS, 10 mM).
Immunohistochemistry
Eight-micron axial sections were cut from paraffin-embedded blocks first at the levels containing the basal ganglia, nucleus anteromedialis thalami, and pars anterior hippocampus (Fig. 1) . Immunohistological analysis for tyrosine hydroxylase (TH) in the striatum and the SNc was performed with a commercially available antibody (Novocastra) at a dilution of 1:20. All sections were deparaffinized with xylene, endogenous peroxidase activity was blocked by incubation in 0.3% methanol peroxide, and the slides were hydrated through graded ethanol. Antigen retrieval was performed by heating for 25 min in a citrate buffer, pH 6, followed by a 15-min cooling period at room temperature. Staining was then carried out using a histomouse kit (BioGenex) specifically designed for use with a mouse monoclonal antibody against mouse tissue. Negative controls omitted the primary antibody.
Axial sections were then cut from paraffin-embedded blocks at deeper levels containing the SNc, substantia nigra pars reticulata (SNr) and hippocampus ( Fig. 2) for quantification of THpositive neurons. In the adjacent section, ApopTag (Intergen) was used according to the manufacturer's specifications to evaluate apoptotic cell death mediated by MPTP.
Quantification
Images (Fig. 1 ) were collected with a Spot 2 digital camera (Diagnostic Instruments, Inc.). The camera white balance and flatfield correction were held constant as was the microscope illumination, and the gain manually set at 1. The digital output from the camera was run through Adobe Photoshop 5.0 via the Twain driver on a Macintosh G3 Power PC.
Data Analyses
Optical density (OD) was obtained with the software application NIH-IMAGE (Wayne Rasband, NIMH). For each mouse, pixel-weighted average OD of the reaction product (TH immunoreactivity) was measured on bilateral striatum from one axial section and an adjacent area of white matter. To minimize inter-subject variability, the magnitude of the reaction product in the striatum was expressed as the ratio between the logarithm of the OD of the striatum and the logarithm of the OD of the adjacent white matter. The ratios were transformed into Van der Waerden scores for normalization and subjected to an analysis of variance using general linear models with ratio as main effect (SAS, SAS Institute, Cary, NC). The null hypothesis was tested with type of knockout and dose of MPTP as interactions. Pairwise comparisons between the mean ratios for the types of knockout mice and the drug doses were carried out with Bonferroni corrections and least squares-adjusted means.
Dopamine Neurochemistry
In addition to quantifying the striatal OD of TH immunoreactivity, striatal dopamine concentrations were measured in another set of mice. In these mice, the brains were removed rapidly without fixation 5 d after the last MPTP injection, and the striatum was dissected out and subsequently stored at Ϫ80ЊC. . Photomicrograph (ϫ20) of TH Immunoreactivity in the Substantia Nigra. SNc, substantia nigra zona compacta; SNr, substantia nigra zona reticulata; H, hippocampus. Dopamine was measured using high performance liquid chromatography with electrochemical detection as described previously (20) .
Quantification of Neurons
In addition to determining changes in striatal TH immunoreactivity and dopamine concentration, the TH-positive as well as TUNEL-positive neurons (ApopTag) in the right and left SNc were counted in 3 TH-immunostained and TUNEL-stained sections from the representative horizontal mesencephalic plane (plane number 141) (21) by two independent observers. The average numbers from each mouse were used for statistical analysis.
RESULTS
Mice
Male and female homozygous knockout mice grew normally and were healthy up to 20 months of age, although there was reduced fertility in the CuZn-SOD deficient mice (18) . There is no difference in the basal levels of Mn-SOD, glutathione reductase, glucose-6-phosphate dehydrogenase, or lipid peroxidation in the major organs including the brain in either the Sod1 -/-or Gpx1 -/-mice (18, 19) . At a dose of 30 mg/kg·d (150 mg/kg cumulative dose protocol), there were mild acute effects of MPTP, such as hypersalivation, which most of the mice recovered from within 30 min. However, one mouse in the Gpx1 -/-group and five mice in the Sod1 -/-group died between 2 and 5 d after the last injection in animals treated with 30mg/kg·d. Most mice treated with MPTP at 60 mg/ kg·d became acutely ill and died within 3 d of treatment.
Tyrosine hydroxylase Immunocytochemistry of Striatum
Littermate control mice given MPTP showed a dosedependent degeneration of the dopaminergic terminal regions in the striatum as assayed by decreased TH OD score (Fig. 3) . Relative TH OD scores in control mice were 1.56 Ϯ 0.08, dose, respectively. Cumulative dose of 150 mg/kg MPTP decreased TH OD scores more than 60% compared with saline-treated controls (p Ͻ 0.01). Decreased striatal TH OD score in mice treated with a cumulative dose of 75 mg MPTP also was statistically significant compared with the vehicle treated controls (p Ͻ 0.05). Striatal TH immunoreactivity of the nerve terminals was dense and continuous along axons in the control mice, but was sparse and punctated in the MPTP-treated mice, indicating dopaminergic nerve terminal degeneration (Fig. 4) . Dose-dependent depletion of TH OD scores was observed in the striatum of both Sod1 -/-and Gpx1 -/-mice treated with MPTP ( Table 1 ). The decrease in TH OD score was significantly greater (Figs. 1, 5 ) in CuZn-SOD deficient or GSHPx-1 deficient mice compared with littermate controls. Two-way analysis of variance comparing TH OD scores were statistically significant among control, CuZn-SOD, and GSHPx-1 deficient mice treated with MPTP at a 75 mg/kg cumulative dose (p Ͻ 0.01). Repeated paired analysis with Bonferroni correction showed significant differences between littermate control and CuZn-SOD deficient or GSHPx-1 deficient mice. There was no significant difference in TH OD scores between CuZn-SOD deficient and GSHPx-1 deficient mice. One-way analysis of variance comparing TH OD scores among control, CuZn-SOD, and GSHPx-1 deficient mice treated with MPTP at a 150 mg/kg cumulative dose also was statistically significant (p Ͻ 0.05). However, repeated paired analysis with Bonferroni correction showed a significant difference only between littermate controls and CuZn-SOD deficient mice. This is probably due to TH OD scores approaching background level in mice treated with a high dose of MPTP.
In addition to quantifying OD scores of TH immunoreactivity, striatal dopamine concentration was determined. The results demonstrated that striatal dopamine loss following exposure to MPTP paralleled decrease in TH OD score. Cumulative dose of 75 or 150 mg/kg MPTP depleted striatal dopamine more than 50% and 65% respectively compared with saline-treated controls (p Ͻ 0.01) ( Table 2) . Dose-dependent depletion of striatal dopamine also was observed in the striatum of both Sod1 -/-and Gpx1 -/-mice treated with MPTP (Table 2) . Two-way analysis of variance comparing dopamine concentrations were statistically significant among control, CuZn-SOD, and GSHPx-1 deficient mice treated with MPTP at a 75 or 150 mg/kg cumulative dose (p Ͻ 0.01). Repeated paired analysis with Bonferroni correction showed the decrease in striatal dopamine was significantly greater in CuZn-SOD deficient or GSHPx-1 deficient mice compared with littermate controls treated with either cumulative dose of 75 or 150 mg/kg MPTP.
Despite significant reduction in TH immunoreactivity and dopamine level in the striatum, this MPTP exposure protocol did not induce a significant dopaminergic neuronal loss in the SNc. The average number of TH-positive neurons in the SNc was 61 Ϯ 5 in littermate control mice treated with vehicle and 52 Ϯ 2 in control mice treated with MPTP at 150 mg/kg cumulative dose (not statistically different). One-way analysis of variance comparing TH-positive neurons in the SNc was not statistically different (p Ͼ 0.05) among control, CuZn-SOD deficient, and GSHPx-1 deficient mice treated with MPTP at 150 mg/kg cumulative dose (Fig. 6 ). In addition, we did not observe any TUNEL-positive neurons in the SNc in any of the groups (data not shown). Although we did not use nonbiased stereologic techniques to count nigral neurons, the lack of even a trend toward more neuronal loss in either knockout strain suggested that the MPTP dosing regimen and timing of sacrifice selected for this study were relatively selective for striatal over nigral damage. Loss of nigral neurons could have been significant if brain tissues were harvested at a later time after last MPTP injection.
DISCUSSION
Consistent with the observations of several laboratories (13, 22, 23) , our results provide evidence that MPTP produces a marked reduction in dopamine content and TH immunoreactivity in the striatum of mice 5 d after exposure. Importantly, our study is the first to demonstrate that MPTP-induced dopaminergic neurodegeneration is significantly enhanced in mice deficient in either CuZn-SOD or GSHPx-1. This suggests that both •O 2 Ϫ and hydroperoxides are involved in the pathogenesis of MPTPinduced neurotoxicity. 
Sod1
ϪlϪ and Gpx1 ϪlϪ mice were exposed to MPTP for 5 days, and the brains harvested 5 days later. Striatal TH immunoreactivity was quantified and expressed as optical density (OD) scores (n ϭ 5 mice in all groups except n ϭ 4 mice in the Gpx1
ϪlϪ group exposed to 150 mg/kg MPTP). Two-way analysis of variance was significantly different (p Ͻ 0.05). Repeated paired analysis with Bonferroni correction showed a significant difference between littermate controls and CuZn-SOD deficient mice treated with MPTP at 75 or 150 mg/kg, and a significant difference between littermate controls and GSHPx-1 deficient mice treated with MPTP at 75 mg/kg. *: p Ͻ 0.01 for control mice treated with vehicle versus those treated with MPTP at 75 or 150 mg/kg.
ϩ : p Ͻ 0.05 for littermate control mice versus either Sod1
ϪlϪ or Gpx1 ϪlϪ mice treated with MPTP at 75 mg/ kg.
: p Ͻ 0.05 for littermate control mice versus Sod1
ϪlϪ mice treated with MPTP at 150 mg/kg. ϪlϪ and Gpx1 ϪlϪ mice were exposed to MPTP for 5 days, and the brains harvested 5 days later. Striatal dopamine was quantified and expressed as ng/mg protein (n ϭ 5 mice in all groups except n ϭ 4 mice in the Sod1
ϪlϪ groups). The increased sensitivity of mice lacking CuZn-SOD to MPTP-induced neurotoxicity observed in this study is consistent with earlier observations showing that mice with increased CuZn-SOD or Mn-SOD are resistant to MPTP-mediated neurotoxicity (10, 11) . In combination, these three studies suggest that •O 2 Ϫ generation is a critical step in MPTP-induced neurodegeneration. The mechanism by which •O 2 Ϫ contributes to dopaminergic neurodegeneration is not fully clarified, but is thought to involve the formation of even more reactive radicals. One of those radicals is peroxynitrite formed through reaction between •O 2 Ϫ and nitric oxide (NO•). Peroxynitrite subsequently inhibits protein function by nitration. One of the common markers of this process is formation of 3-nitrotyrosine (10) . It has been shown that MPTP administration is associated with increased 3-nitrotyrosine concentration in the striatum, and inhibition of nitric oxide synthase (NOS) not only inhibits formation of 3-nitrotyrosine, but also protects against MPTP toxicity both in mice and in primates (10, 14, 24) . Nitrotyrosine also has been localized immunohistologically to Lewy bodies of the substantia nigra from patients with idiopathic PD (25) . In addition, peroxynitrite can decompose to form •OH and nitrogen dioxide radicals (26) , thereby initiating lipid peroxidation and DNA oxidation, phenomena well documented in nigral tissue from PD patients (27) (28) (29) . Interestingly, the role of NO• in MPTP-induced toxicity has been challenged recently because 7-nitroindazole, a NOS inhibitor, may also act as a MAO inhibitor or as an atypical antioxidant (30) (31) (32) .
In addition to forming peroxynitrite, •O 2 Ϫ can produce H 2 O 2 by metal-or enzyme-catalyzed reactions. H 2 O 2 can then mediate •OH formation in the presence of transitional metals such as iron, which is significantly increased in the nigral tissue of PD patients (16) . H 2 O 2 is detoxified by catalase and GSHPx-1, but primarily by GSHPx-1 due to its lower Km (15) . In this study, GSHPx-1 deficient mice were significantly more susceptible to striatal dopaminergic damage from MPTP administration compared with littermate control mice. The extent of enhancement of MPTP toxicity was comparable to the results obtained in Sod1 -/-mice. These findings provide direct evidence that formation of hydroperoxides plays a significant role in the pathogenesis of MPTP-induced neurotoxicity.
How might increased ROS generation mediate neurodegeneration? The cellular targets of oxidative stress are not well understood, although mitochondria have been proposed as one of the major sites (33) (34) (35) . Mitochondria consume over 90% of the cell's oxygen, and the mitochondrial respiratory chain is a major source of •O 2 Ϫ under normal conditions (36) . Inhibition of mitochondrial complex I, a well-known effect of MPP ϩ , which is also observed in the SN from PD patients (35) , may lead to generation of ROS, further inhibiting mitochondrial complex I. This negative cycle is likely to be exaggerated in mice deficient in either cellular CuZn-SOD or GSHPx-1 due to their compromised antioxidative capacity, resulting in enhanced MPTP toxicity. In addition, •O 2 Ϫ and H 2 O 2 can potentiate each other in mediating oxidative Ϫ and H 2 O 2 inhibit catalase and SOD respectively (15) . Finally, enhancement of MPTP neurotoxicity in knockout mice could also be due to indirect effects on sites involved in the metabolism of MPTP, e.g. the dopamine transporter and vesicular monoamine transporters that have been shown to influence MPTP neurotoxicity (37) . In either case, due to the dosing protocol of MPTP employed in these studies, the results suggest that MPTP-induced production of •O 2 Ϫ and H 2 O 2 are early events in dopaminergic neurodegeneration that precede nigral neurodegeneration.
In summary, we observed significantly greater MPTP neurotoxicity in mice lacking either CuZn-SOD or GSHPx-1 compared with littermate control mice. These data provide direct evidence that some of the deleterious effects of MPTP are mediated by both •O 2 Ϫ and hydroperoxides. The similarity between the MPTP model and PD further raises the possibility that both types of ROS may play a significant role in the etiology of dopaminergic neurodegeneration in PD.
